Ignite Creation Date:
2024-05-06 @ 3:39 AM
Last Modification Date:
2024-10-26 @ 11:36 AM
Study NCT ID:
NCT02332213
Status:
COMPLETED
Last Update Posted:
2018-08-21
First Post:
2014-12-30
Brief Title:
Volatile Markers in Digestive Cancer
Sponsor:
University of Latvia
Organization:
University of Latvia
Study Overview
Official Title:
Volatile Marker Testing for Digestive Cancer and Precancerous Lesion Detection Evaluation of Confounding Factors
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VOLGACORE
Brief Summary:
The study is aimed to determine the potential of volatile marker testing for identification of gastrointestinal cancers in particular - colorectal and gastric cancers the related precancerous lesions in the stomach and colon
The study will be addressing the role of confounding factors including lifestyle factors diet smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers
The study will be addressing the role of confounding factors including lifestyle factors diet smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers
Detailed Description:
Patients with established disease cancer precancerous lesions as well as patients investigated for the lesions and having been documented lack of the lesions will be enrolled to the study at clinical sites in Europe Latvia Lithuania In addition group of persons from general population at average risk for developing the target disease will be also enrolled
Testing of volatile markers will be conducted by one of two methods 1 gas chromatography coupled to mass spectroscopy GS-MS and 2 nanosensor technology
Volunteers including patients with established disease will be enrolled prior the removal of the target lesion eg surgery for cancer or polypectomy in the case of a polyp
The study will be conducted by utilizing the experience of institutions in the European Union and Israel
Testing of volatile markers will be conducted by one of two methods 1 gas chromatography coupled to mass spectroscopy GS-MS and 2 nanosensor technology
Volunteers including patients with established disease will be enrolled prior the removal of the target lesion eg surgery for cancer or polypectomy in the case of a polyp
The study will be conducted by utilizing the experience of institutions in the European Union and Israel
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| LZP Nr 201410-5 | OTHER | Latvian Research Council | None |